{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:09Z","timestamp":1792716909481,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40257-018-0360-y","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T05:52:08Z","timestamp":1526017928000},"page":"647-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Daylight Photodynamic Therapy for Actinic Keratoses"],"prefix":"10.1007","volume":"19","author":[{"given":"Colin A.","family":"Morton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse R.","family":"Braathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","volume":"56","author":"LR Braathen","year":"2007","unstructured":"Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. J Am Acad Dermatol. 2007;56:125\u201343.","journal-title":"J Am Acad Dermatol"},{"key":"360_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","volume":"159","author":"CA Morton","year":"2008","unstructured":"Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy. Br J Dermatol. 2008;159:1245\u201366.","journal-title":"Br J Dermatol"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jdv.12031","volume":"27","author":"CA Morton","year":"2013","unstructured":"Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications\u2014actinic keratoses, Bowen\u2019s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27:536\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1684\/ejd.2015.2570","volume":"25","author":"C Morton","year":"2015","unstructured":"Morton C, Szeimies RM, Sidoroff A, Wennberg AM, Basset-Seguin N, Calzavara-Pinton P, et al. European Dermatology Forum European Dermatology Forum Guidelines on topical photodynamic therapy. Eur J Dermatol. 2015;25:296\u2013311.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"360_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.140.1.33","volume":"140","author":"D Touma","year":"2004","unstructured":"Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140(1):33\u201340.","journal-title":"Arch Dermatol"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"23259","DOI":"10.3390\/ijms161023259","volume":"16","author":"M Kim","year":"2015","unstructured":"Kim M, Jung HY, Park HJ. Topical PDT in the treatment of benign skin diseases: principles and new applications. Int J Mol Sci. 2015;16:23259\u201378.","journal-title":"Int J Mol Sci"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1039\/9781847551658-00177","volume-title":"photodynamic therapy","author":"C Fritsch","year":"2003","unstructured":"Fritsch C, Lang K, Schulte KW, Neuse W, Ruzicka T, Lehman P. Fluorescence diagnosis and photodynamic therapy in dermatology: an overview. In: Patrice T, editor. photodynamic therapy. Cambridge: Royal Society of Chemistry; 2003. p. 177\u2013212."},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2230.2002.01065.x","volume":"27","author":"S Grapengiesser","year":"2002","unstructured":"Grapengiesser S, Ericson M, Gudmundsson F, Lark\u00f6 O, Ros\u00e9n A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1468-3083.2011.04386.x","volume":"26","author":"SR Wiegell","year":"2012","unstructured":"Wiegell SR, Wulf HC, Szeimies RM, Basset-Seguin N, Bissonnette R, Gerritsen MJ, et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol. 2012;26:673\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pdpdt.2016.11.012","volume":"17","author":"H Osman-Ponchet","year":"2017","unstructured":"Osman-Ponchet H, Sevin K, Gaborit A. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation. Photodiagnosis Photodyn Ther. 2017;17:75\u201381.","journal-title":"Photodiagnosis Photodyn Ther."},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.13449","volume":"30","author":"P Gholam","year":"2016","unstructured":"Gholam P, Fink C, Bosselmann I, Enk AH. Retrospective analysis evaluating the effect of a keratolytic and physical pretreatment with salicylic acid, urea and curettage on the efficacy and safety of photodynamic therapy of actinic keratoses with methylaminolaevulinate. J Eur Acad Dermatol Venereol. 2016;30:619\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/bjd.13284","volume":"171","author":"SR Wiegell","year":"2014","unstructured":"Wiegell SR, Petersen B, Wulf HC. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial. Br J Dermatol. 2014;171:1487\u201392.","journal-title":"Br J Dermatol"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2011.10209.x","volume":"164","author":"SR Wiegell","year":"2011","unstructured":"Wiegell SR, Fabricius S, Stender IM, Berne B, Kroon S, Andersen BL, et al. A randomized, multicentre study of directed daylight exposure times of 1(1\/2) vs. 2(1\/2) h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol. 2011;164:1083\u201390.","journal-title":"Br J Dermatol"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2012.11200.x","volume":"168","author":"SR Wiegell","year":"2013","unstructured":"Wiegell SR, Fabricius S, Heydenreich J, Enk CD, Rosso S, B\u00e4umler W, et al. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol. 2013;168:186\u201391.","journal-title":"Br J Dermatol"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1111\/ijd.13256","volume":"55","author":"B Grinblat","year":"2016","unstructured":"Grinblat B, Galimberti G, Pantoja G, et al. Feasibility of daylight-mediated photodynamic therapy for actinic keratosis throughout the year in Central and South America: a meteorological study. Int J Dermatol. 2016;55:e488\u201393.","journal-title":"Int J Dermatol"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ajd.12295","volume":"57","author":"L Spelman","year":"2016","unstructured":"Spelman L, Rubel D, Murrell DF, et al. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study. Australas J Dermatol. 2016;57:24\u20138.","journal-title":"Australas J Dermatol"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","volume":"166","author":"T Dirschka","year":"2012","unstructured":"Dirschka T, Radny P, Dominicus R, Mensing H, Br\u00fcning H, Jenne L, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol. 2012;166:137\u201346.","journal-title":"Br J Dermatol"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","volume":"158","author":"SR Wiegell","year":"2008","unstructured":"Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol. 2008;158:740\u20136.","journal-title":"Br J Dermatol"},{"key":"360_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","volume":"160","author":"SR Wiegell","year":"2009","unstructured":"Wiegell SR, Haedersdal M, Eriksen P, Wulf HC. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol. 2009;160:1308\u201314.","journal-title":"Br J Dermatol"},{"key":"360_CR20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1365-2133.2012.10833.x","volume":"166","author":"SR Wiegell","year":"2012","unstructured":"Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, et al. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol. 2012;166:1327\u201332.","journal-title":"Br J Dermatol"},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/bjd.13138","volume":"171","author":"DM Rubel","year":"2014","unstructured":"Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, et al. Daylight PDT with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional PDT in actinic keratosis treatment: a randomised controlled trial. Br J Dermatol. 2014;171:1164\u201371.","journal-title":"Br J Dermatol"},{"key":"360_CR22","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol. 2015;29:2342\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR23","doi-asserted-by":"publisher","unstructured":"Fargnoli MC, Ibbotson SH, Hunger RE, Rostain G, Gaastra MTW, Eibenschutz L, et al. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight-photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in 6 European countries. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.14691 (Epub 14 Nov 2017).","DOI":"10.1111\/jdv.14691"},{"key":"360_CR24","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.13076","volume":"29","author":"MC Fargnoli","year":"2015","unstructured":"Fargnoli MC, Piccioni A, Neri L, et al. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison\u00a0study in Italy. J Eur Acad Dermatol Venereol. 2015;29:1926\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.2340\/00015555-1425","volume":"92","author":"LR Braathen","year":"2012","unstructured":"Braathen LR. Daylight photodynamic therapy in private practice in Switzerland: gain without pain. Acta Derm Venereol. 2012;92:652\u20133.","journal-title":"Acta Derm Venereol"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/phpp.12127","volume":"31","author":"BM Grinblat","year":"2015","unstructured":"Grinblat BM, Festa Neto C, Sanches JA Jr, Szeimies RM, Oliveira AP, Torezan LA. Daylight photodynamic therapy for actinic keratoses in S\u00e3o Paulo. Brazil. Photodermatol Photoimmunol Photomed. 2015;31:54\u20136.","journal-title":"Brazil. Photodermatol Photoimmunol Photomed."},{"key":"360_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1590\/abd1806-4841.20175175","volume":"92","author":"LEG Galv\u00e3o","year":"2017","unstructured":"Galv\u00e3o LEG, Gon\u00e7alves HS, Botelho KP, Caldas JC. Daylight photodynamic therapy - Experience and safety in treatment of actinic keratoses of the face and scalp in low latitude and high brightness region. Anais Brasileiros de Dermatologia. 2017;92:142\u20134.","journal-title":"Anais Brasileiros de Dermatologia."},{"key":"360_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/bjd.13326","volume":"171","author":"N Neittaanm\u00e4ki-Perttu","year":"2014","unstructured":"Neittaanm\u00e4ki-Perttu N, Karppinen TT, Gr\u00f6nroos M, Tani TT, Snellman E. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Br J Dermatol. 2014;171:1172\u201380.","journal-title":"Br J Dermatol"},{"key":"360_CR29","unstructured":"EU Clinical Trials Register. EudraCT number 2015-004382-83. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2015-004382-83\/results . Accessed 22 Apr 2018."},{"key":"360_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1684\/ejd.2016.2882","volume":"27","author":"MC Fargnoli","year":"2017","unstructured":"Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp. Eur J Dermatol. 2017;27:89\u201391.","journal-title":"Eur J Dermatol"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/01.TP.0000107284.04969.5C","volume":"77","author":"G Dragieva","year":"2004","unstructured":"Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen\u2019s disease in transplant recipients. Transplantation. 2004;77:115\u201321.","journal-title":"Transplantation"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","volume":"156","author":"CM Perrett","year":"2007","unstructured":"Perrett CM, McGregor JM, Warwick J, Karran P, Leigh IM, Proby CM, et al. Treatment of posttransplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007;156:320\u20138.","journal-title":"Br J Dermatol"},{"key":"360_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/bjd.13222","volume":"172","author":"K Togsverd-Bo","year":"2015","unstructured":"Togsverd-Bo K, Lei U, Erlendsson AM, Taudorf EH, Philipsen PA, Wulf HC, et al. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients: a randomized controlled trial. Br J Dermatol. 2015;172:467\u201374.","journal-title":"Br J Dermatol"},{"key":"360_CR34","doi-asserted-by":"crossref","unstructured":"Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev 2012;(12):CD004415.","DOI":"10.1002\/14651858.CD004415.pub2"},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamadermatol.2014.1253","volume":"150","author":"G Patel","year":"2014","unstructured":"Patel G, Armstrong AW, Eisen DB. Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta - analysis. JAMA Dermatol. 2014;150:1281\u20138.","journal-title":"JAMA Dermatol"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/bjd.15107","volume":"176","author":"D Berker de","year":"2017","unstructured":"de Berker D, McGregor JM, Mohd Mustapa MF, Exton LS, Hughes BR. British Association of Dermatologists\u2019 guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol. 2017;176:20\u201343.","journal-title":"Br J Dermatol"},{"key":"360_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/dth.12334","volume":"29","author":"G Genovese","year":"2016","unstructured":"Genovese G, Fai D, Fai C, Mavilia L, Mercuri SR. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis. Dermatol Ther. 2016;29:191\u20136.","journal-title":"Dermatol Ther"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"25912","DOI":"10.3390\/ijms161025912","volume":"16","author":"SR Lucena","year":"2015","unstructured":"Lucena SR, Salazar N, Gracia-Caza\u00f1a T, Zamarr\u00f3n A, Gonz\u00e1lez S, Juarranz A, et al. Combined treatments with photodynamic therapy for non-melanoma skin cancer. Int J Mol Sci. 2015;16:25912\u201333.","journal-title":"Int J Mol Sci"},{"key":"360_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2340\/00015555-2612","volume":"97","author":"CV Nissen","year":"2017","unstructured":"Nissen CV, Heerfordt IM, Wiegell SR, Mikkelsen CS, Wulf HC. Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2017;97:617\u201321.","journal-title":"Acta Derm Venereol"},{"key":"360_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/120347540200600301","volume":"6","author":"D Czarnecki","year":"2002","unstructured":"Czarnecki D, Meehan CJ, Bruce F, Culjak G. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002;6:207\u20139.","journal-title":"J Cutan Med Surg"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2133.2009.09492.x","volume":"162","author":"Z Apalla","year":"2010","unstructured":"Apalla Z, Sotiriou E, Chovarda E, Lefaki I, Devliotou-Panagiotidou D, Ioannides D. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol. 2010;162:171\u20135.","journal-title":"Br J Dermatol"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"U Reinhold","year":"2016","unstructured":"Reinhold U, Dirschka T, Ostendorf R, Aschoff R, Berking C, Philipp-Dormston WG, et al. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u00ae) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy when using the BF-RhodoLED\u00ae lamp. Br J Dermatol. 2016;175:696\u2013705.","journal-title":"Br J Dermatol"},{"key":"360_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/jdv.14177","volume":"31","author":"E Sotiriou","year":"2017","unstructured":"Sotiriou E, Apalla Z, Vrani F, et al. Daylight photodynamic therapy vs Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study. J Eur Acad Dermatol Venereol. 2017;31:1303\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00015550510042868","volume":"86","author":"HC Wulf","year":"2006","unstructured":"Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006;86:25\u20138.","journal-title":"Acta Derm Venereol"},{"key":"360_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/TP.0b013e318180731e","volume":"86","author":"AM Wennberg","year":"2008","unstructured":"Wennberg AM, Stenquist B, Stockfleth E, et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation. 2008;86:423\u20139.","journal-title":"Transplantation"},{"key":"360_CR46","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1159\/000453610","volume":"232","author":"I Seubring","year":"2016","unstructured":"Seubring I, Groenewoud JMM, Gerritsen MP. Comparison of \u201cLesion-by-Lesion\u201d and field photodynamic therapy in the prevention of actinic keratoses: a randomized, split-face, Single-Blind Pilot Study. Dermatology. 2016;232:708\u201314.","journal-title":"Dermatology"},{"key":"360_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1468-3083.2011.04432.x","volume":"26","author":"LR Braathen","year":"2012","unstructured":"Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJP, Gilaberte Y, et al. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol. 2012;26:1063\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR48","first-page":"742","volume":"28","author":"R Ruiz-Rodriguez","year":"2002","unstructured":"Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S, et al. Photodynamic photorejuvenation. Dermatol Surg. 2002;28:742\u20134.","journal-title":"Dermatol Surg"},{"key":"360_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1524-4725.2009.01385.x","volume":"36","author":"MC Issa","year":"2010","unstructured":"Issa MC, Pineiro-Maceira J, Vieira MT, Olej B, Mandarim-de-Lacerda CA, Luiz RR, et al. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg. 2010;36:39\u201348.","journal-title":"Dermatol Surg"},{"key":"360_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/09546634.2011.590791","volume":"22","author":"A Piccioni","year":"2011","unstructured":"Piccioni A, Fargnoli MC, Schoinas S, Suppa M, Frascione P, Ginebri A, et al. Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin. J Dermatol Treat. 2011;22:247\u201353.","journal-title":"J Dermatol Treat."},{"key":"360_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1468-3083.2010.03687.x","volume":"25","author":"G Sanclemente","year":"2011","unstructured":"Sanclemente G, Medina L, Villa JF, Barrera LM, Garcia HI. A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate\u2009+\u2009red-light in patients with facial photodamage. J Eur Acad Dermatol Venereol. 2011;25:49\u201358.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaad.2009.06.025","volume":"62","author":"MY Park","year":"2010","unstructured":"Park MY, Sohn S, Lee ES, Kim YC. Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis: a histologic analysis. J Am Acad Dermatol. 2010;62:85\u201395.","journal-title":"J Am Acad Dermatol"},{"key":"360_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2133.2012.10887.x","volume":"167","author":"RM Szeimies","year":"2012","unstructured":"Szeimies RM, Torezan L, Niwa A, Valente N, Unger P, Kohl E, et al. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol. 2012;167:150\u20139.","journal-title":"Br J Dermatol"},{"key":"360_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2133.2011.10270.x","volume":"165","author":"L Bagazgoitia","year":"2011","unstructured":"Bagazgoitia L, Cuevas Santos J, Juarranz A, Jaen P. Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. Br J Dermatol. 2011;165:144\u201351.","journal-title":"Br J Dermatol"},{"key":"360_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.13327","volume":"30","author":"WG Philipp-Dormston","year":"2016","unstructured":"Philipp-Dormston WG, Sanclemente G, Torezan L, et al. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of \u2018actinic field damage\u2019: recommendations of an international expert group. J Eur Acad Dermatol Venereol. 2016;30:8\u201315.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR56","first-page":"224","volume":"107","author":"G Sanclemente","year":"2016","unstructured":"Sanclemente G, Mancilla GA, Hernandez G. A double-blind randomized controlled trial to assess the efficacy of daylight photodynamic therapy with methyl-aminolevulinate vs. Placebo and daylight in patients with facial photodamage. Actas Dermo-Sifiliogr\u00e1ficas. 2016;107:224\u201334.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"360_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12895-017-0064-7","volume":"17","author":"E Kohl","year":"2017","unstructured":"Kohl E, Koller M, Zeman F, et al. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face\u2014protocol of a multicenter, prospective, randomized, controlled, two-armed study. BMC Dermatol. 2017;17:12.","journal-title":"BMC Dermatol."},{"key":"360_CR58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/lsm.22323","volume":"47","author":"KL Lane","year":"2015","unstructured":"Lane KL, Hovenic W, Ball K, Zachary CB. Daylight photodynamic therapy: the Southern California experience. Lasers Surg Med. 2015;47:168\u201372.","journal-title":"Lasers Surg Med"},{"key":"360_CR59","first-page":"353","volume":"5","author":"A Kasche","year":"2006","unstructured":"Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol. 2006;5:353\u20136.","journal-title":"J Drugs Dermatol"},{"key":"360_CR60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2340\/00015555-2205","volume":"96","author":"N Neittaanm\u00e4ki-Perttu","year":"2016","unstructured":"Neittaanm\u00e4ki-Perttu N, Gr\u00f6nroos M, Karppinen T, Snellman E, Rissanen P. Photodynamic Therapy for Actinic Keratoses: A Randomized Prospective Non-sponsored Cost-effectiveness Study of Daylight-mediated Treatment Compared with Light-emitting Diode Treatment. Acta Derm Venereol. 2016;96:241\u20134.","journal-title":"Acta Derm Venereol."},{"key":"360_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/ijms17030309","volume":"17","author":"CM Lerche","year":"2016","unstructured":"Lerche CM, Heerfordt IM, Heydenreich J, Wulf HC. Alternatives to outdoor daylight illumination for photodynamic therapy: use of greenhouses and artificial light sources. Int J Mol Sci. 2016;17:309.","journal-title":"Int J Mol Sci"},{"key":"360_CR62","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bjd.13420","volume":"172","author":"C Kellner","year":"2015","unstructured":"Kellner C, Bauriedl S, Hollstein S, Reinhold U. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study. Br J Dermatol. 2015;172:1146\u20138.","journal-title":"Br J Dermatol"},{"key":"360_CR63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jamadermatol.2015.5436","volume":"152","author":"SM O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman SM, Clowry J, Manley M, McCavana J, Gray L, Kavanagh A, et al. Artificial white light vs daylight photodynamic therapy for actinic keratoses: a randomized clinical trial. JAMA Dermatol. 2016;152:638\u201344.","journal-title":"JAMA Dermatol."},{"key":"360_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/dth.12258","volume":"28","author":"D Fai","year":"2015","unstructured":"Fai D, Romanello E, Brumana MB, et al. Daylight photodynamic therapy with methyl-aminolevulinate for the treatment of actinic cheilitis. Dermatol Ther. 2015;28:355\u201368.","journal-title":"Dermatol Ther"},{"key":"360_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jdv.12076","volume":"28","author":"SR Wiegell","year":"2014","unstructured":"Wiegell SR, Sk\u00f8dt V, Wulf HC. Daylight-mediated photodynamic therapy of basal cell carcinomas\u2014an explorative study. J Eur Acad Dermatol Venereol. 2014;28:169\u201375.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/1346-8138.13191","volume":"43","author":"HH Kwon","year":"2016","unstructured":"Kwon HH, Moon KR, Park SY, Yoon JY, Suh DH, Lee JB. Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: A double-blind randomized controlled trial. J Dermatol. 2016;43:515\u201321.","journal-title":"J Dermatol"},{"key":"360_CR67","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/bjd.13490","volume":"172","author":"CD Enk","year":"2015","unstructured":"Enk CD, Nasereddin A, Alper R, Dan-Goor M, Jaffe CL, Wulf HC. Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modality. Br J Dermatol. 2015;172:1364\u201370.","journal-title":"Br J Dermatol."},{"key":"360_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/ajd.12354","volume":"57","author":"JA See","year":"2016","unstructured":"See JA, Shumack S, Murrell DF, Rubel DM, Fern\u00e1ndez-Pe\u00f1as P, Salmon R, et al. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol. 2016;57:167\u201374.","journal-title":"Australas J Dermatol"},{"key":"360_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/phpp.12221","volume":"32","author":"B Grinblat","year":"2016","unstructured":"Grinblat B, Galimberti G, Chouela E, Sanclemente G, Lopez M, Alcala D, et al. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations. Photodermatol Photoimmunol Photomed. 2016;32:81\u20137.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"360_CR70","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/jdv.12974","volume":"29","author":"CA Morton","year":"2015","unstructured":"Morton CA, Wulf HC, Szeimies RM, Gilaberte Y, Basset-Seguin N, Sotiriou E, et al. Practical approach to the use of daylight photodynamic therapy with topical methylaminolevulinate for actinic keratosis: a European consensus. J Eur Acad Dermatol Venereol. 2015;29:1718\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"360_CR71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/09546634.2016.1240863","volume":"28","author":"S Ibbotson","year":"2017","unstructured":"Ibbotson S, Stones R, Bowling J, Campbell S, Kownacki S, Sivaramakrishnan M, et al. A consensus on the use of daylight photodynamic therapy in the UK. J Dermatolog Treat. 2017;28:360\u20137.","journal-title":"J Dermatolog Treat."},{"key":"360_CR72","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ad.2015.06.001","volume":"106","author":"Y Gilaberte","year":"2015","unstructured":"Gilaberte Y, Aguilar M, Almagro M, Correia O, Guill\u00e9n C, Harto A, et al. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis. Actas Dermosifiliogr. 2015;106:623\u201331.","journal-title":"Actas Dermosifiliogr."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-018-0360-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:20:46Z","timestamp":1693668046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-018-0360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0360-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"assertion":[{"value":"11 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this manuscript","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Colin A. Morton has been a member of advisory boards for Almirall, Biofrontera, Galderma, and Leo Pharma, and has received speaker honoraria from Biofrontera and Galderma. Lasse R. Braathen has received congress\/travel support, and fees for lectures and advisory board participation from Galderma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}